JAMA Network Open
-
healthDiabetes Drugs Show Potential to Curb Dementia in Psychiatric Patients
A US Department of Veterans Affairs study finds SGLT2 inhibitors may reduce all-cause dementia risk by up to 46% in older adults with mood or psychotic disorders.
-
healthTargeted Cognitive Therapy Yields Lasting Relief for Long COVID Brain Fog
A randomized trial reveals goal-focused cognitive rehabilitation produces significant and durable improvements in daily function for patients suffering from long COVID-related cognitive impairment.
-
healthSepsis Remote Monitoring Fails to Lower Readmissions in Major Trial
A randomized clinical trial found remote patient monitoring after sepsis or lung infection did not improve recovery time at home or reduce hospital readmissions, especially among older adults.
-
healthMental Health Diagnostic Interviews Vary in Reliability, New Study Finds
A new study in JAMA Network Open shows diagnostic interviews for mental disorders have varying reliability, with substance use disorders being more consistent than others.
-
healthNew Study Links Early Neonatal Infections to Cerebral Palsy Risk
A large Danish study shows early-onset sepsis and meningitis strongly increase cerebral palsy risk and severity in near-term and full-term infants.
-
healthEMR Alert Boosts Chlamydia Screening in Primary Care
Real-time electronic alerts for medical assistants increased chlamydia test orders in primary care, but not in ob-gyn practices.
-
healthArsenic in Drinking Water Linked to Increased Urologic Cancer Risk
A meta-analysis finds arsenic, cadmium, and vanadium increase urologic cancer risk, with arsenic showing the strongest association.
-
healthNew IL-17 Drug Shows Promise for Axial Spondyloarthritis
Phase 3 trial finds vunakizumab significantly improves symptoms in radiographic axial spondyloarthritis with sustained benefits and a favorable safety profile.